Mazini Loubna, Matar Nourredine, Bouhya Said, Marzouk Diaa, Anwar Wagida, Khyatti Meriem
Laboratoire Cellules Souches et Thérapie Cellulaire, Institut Pasteur Maroc, Casablanca, 1 Place Pasteur, 20360 Casablanca, Morocco.
Service Gynécologie Obstétrique, Matérnité Lalla Meryem B, Centre Hospitalier Universitaire (CHU) Ibn Rochd, Casablanca, Morocco. ; Both the authors equally contributed to this work.
J Stem Cells Regen Med. 2014 Nov 28;10(2):28-37. doi: 10.46582/jsrm.1002006. eCollection 2014.
Since the success of the first umbilical cord blood (UCB) transplantation in a child with Fanconi anaemia in 1989, great interests have emerged for this source of stem cells. UCB provides an unlimited source of ethnically diverse stem cells and is an alternative for bone marrow (BM) and peripheral blood (PB) haematopoietic stem cell transplantation (HSCT). Thus, UCB and manipulated stem cells are now collected and banked according to international accreditation standards for listing on registries allowing rapid search and accessibility worldwide. This work aims to identify problems limiting the creation of a Moroccan cord blood bank and to highlight opportunities and issues of a new legislation promoting additional applications of cell therapy.
自1989年首例脐带血(UCB)移植在一名患有范可尼贫血的儿童身上取得成功以来,人们对这种干细胞来源产生了浓厚兴趣。脐带血提供了种族多样的无限干细胞来源,是骨髓(BM)和外周血(PB)造血干细胞移植(HSCT)的替代选择。因此,现在脐带血和经过处理的干细胞是按照国际认证标准进行采集和储存的,以便列入登记册,从而在全球范围内实现快速检索和获取。这项工作旨在找出限制摩洛哥脐带血库建立的问题,并强调一项促进细胞治疗更多应用的新立法所带来的机遇和问题。